Coca Cola Co (KO) · Oct 27, 2026 · Earnings
Beat — Comparable EPS $0.91 vs ~$0.87-$0.88 consensus; revenue $13.38B vs ~$12.92B
Coca-Cola earnings beat Q3 expectations, with 7% organic growth and higher full-year EPS and cash-flow guidance.
Coca-Cola is pursuing steady global beverage growth through brand investment, pricing, innovation and a more asset-light bottling system; its stated strategy centers on shaping its portfolio, transforming marketing and optimizing the Coca-Cola ecosystem.
The quarter cleared expectations across the top line and earnings. Pre-release estimates clustered around roughly $12.9 billion of revenue and $0.87-$0.88 of EPS; Coca-Cola delivered $13.38 billion of revenue and $0.91 of comparable EPS. The filing says, “Net revenues grew 7% to $13.4billion, and organic revenues (non-GAAP) grew 7%,” making this a genuine operating beat rather than a result carried only by accounting items.
| Metric | Q3 2026 | Prior-year Q3 | Change / expectation |
|---|---|---|---|
| Net operating revenues | $13.38B | $12.46B | +7%; above ~$12.92B consensus (Consolidated Statements of Income) |
| Comparable EPS | $0.91 | $0.82 | +11%; above ~$0.87-$0.88 consensus (EPS reconciliation) |
| Comparable currency-neutral EPS | — | — | +9% (EPS reconciliation) |
| Comparable operating margin | 32.9% | 31.9% | +100 bps (Operating Margin reconciliation) |
| Free cash flow, nine months | $11.41B | $3.65B operating cash flow | 2026 target raised to at least $13.0B (Cash Flow statement; Guidance) |
The guidance increase is the more important change to the standing story. Management lifted 2026 organic-revenue guidance from approximately 5% growth to at least 5%, comparable currency-neutral EPS excluding acquisitions and divestitures from 7%-8% growth to at least 9%, comparable EPS from 9%-10% growth to at least 11%, and free-cash-flow guidance from approximately $12.4 billion to at least $13.0 billion (Full Year 2026 Guidance). That is a broad improvement, not just a higher reported EPS number helped by currency. The filing explicitly ties the update to “sustained momentum” and “updated full year guidance,” 〔0〕.
Underlying growth is solid, but not explosive. Organic revenue rose 7%, while unit case volume grew only 1% and price/mix contributed 1%; concentrate sales ran two points ahead of unit case volume because of shipment timing (Revenue and Volume reconciliation). The beat therefore reflects a combination of pricing, mix, geographic strength and favorable shipment timing rather than a major acceleration in consumer volume. North America revenue grew 3% in the quarter, while Latin America grew 25%, helped substantially by currency (Operating Segments table).
Profitability improved despite continued investment. Comparable operating margin expanded to 32.9% from 31.9%, and comparable currency-neutral operating income increased 8%; management said higher marketing and operating expenses partly offset the benefit of organic growth (Operating Margin reconciliation). The filing states, “Comparable operating margin (non-GAAP) was 32.9% versus 31.9% in the prior year,” 〔1〕. That supports the higher EPS outlook, although the margin expansion was helped by currency and does not signal a dramatic cost reset.
The bottling transition remains a meaningful source of noise. The updated fourth-quarter assumptions include an approximately 4% headwind to comparable revenue and 3% headwind to comparable EPS from acquisitions and divestitures, assuming the pending African bottling sale closes during Q4 2026 (Fourth Quarter 2026 Considerations). That transaction is not a new strategic surprise, but its timing will distort reported comparisons and make the underlying brand and volume trends harder to read.
Bottom line: This is a clean earnings beat paired with a broad guidance raise, strengthening Coke’s story of dependable organic growth and margin resilience. The main limitation is that volume growth remains modest, so the upgrade is an execution and pricing win—not evidence of a sharp demand acceleration.
Africa bottling sale closing, Q4 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!